This inventor holds 4 USPTO granted patents and 5 published patent applications. Top assignees: Empathbio, Inc., Atai Therapeutics Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: The Innovations of Nicholas Morra
Introduction
Nicholas Morra is an accomplished inventor based in California, known for his contributions to the field of chemistry and pharmacology. With a total of 4 patents, he has made significant strides in the development of novel compounds and synthesis processes.
Latest Patents
Morra's latest patents include innovative work on N,N-dimethyltryptamine (DMT) salts and crystalline salt forms, specifically a crystalline form of DMT succinate. Additionally, he has developed a process for the synthesis of MDMA and its optically active isomers, (R)-3,4-methylenedioxymethamphetamine and (S)-3,4-methylenedioxymethamphetamine.
Career Highlights
Throughout his career, Morra has worked with notable companies such as EmpathBio, Inc. and Atai Therapeutics Inc. His work has focused on advancing therapeutic applications of psychoactive compounds, contributing to the growing field of mental health treatment.
Collaborations
Some of his notable coworkers include Majed Fawaz and Setu Kasera, who have collaborated with him on various projects aimed at enhancing the understanding and application of his inventions.
Conclusion
Nicholas Morra's innovative work in the field of chemistry has led to significant advancements in the synthesis of important compounds. His contributions continue to influence the landscape of pharmacological research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile